Monthly Archives: July 2020

StrategyShare2020 to proceed in virtual sessions

Posted on July 15, 2020 by Gastroenterology Journal

Originally scheduled for June, StrategyShare2020 will now be presented through a series of three 90-minute, virtual sessions beginning Sept. 29. Content will build from one session to the next, and each session will include presentations on topics rela… Continue reading →

Posted in News | Comments Off on StrategyShare2020 to proceed in virtual sessions

AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review

Posted on July 14, 2020 by Gastroenterology Journal

Thanks to ready access to hydrogen breath testing, small intestinal bacterial overgrowth is now commonly diagnosed among individuals presenting with a variety of gastrointestinal and even non-gastrointestinal complaints and is increasingly implicated, … Continue reading →

Posted in News | Comments Off on AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review

Risk of Small Bowel Adenocarcinoma, Adenomas, and Carcinoids in a Nationwide Cohort of Individuals With Celiac Disease

Posted on July 14, 2020 by Gastroenterology Journal

The incidence of small bowel cancers is increasing. Associations have been made between celiac disease and small bowel cancers, but there have been no detailed studies of large cohorts. Continue reading →

Posted in News | Comments Off on Risk of Small Bowel Adenocarcinoma, Adenomas, and Carcinoids in a Nationwide Cohort of Individuals With Celiac Disease

Comparative Efficacy Trials in Inflammatory Bowel Disease

Posted on July 14, 2020 by Gastroenterology Journal

We may stumble and fall but shall rise again; it should be enough if we did not run away from the battle. Continue reading →

Posted in News | Comments Off on Comparative Efficacy Trials in Inflammatory Bowel Disease

Assessment of evidence quality in IBD guidance: The use and misuse of GRADE

Posted on July 14, 2020 by Gastroenterology Journal
Posted in News | Comments Off on Assessment of evidence quality in IBD guidance: The use and misuse of GRADE

Insights from Pharmacovigilance: Gastrointestinal Related Immune Checkpoint Inhibitor Adverse Events

Posted on July 14, 2020 by Gastroenterology Journal
Posted in News | Comments Off on Insights from Pharmacovigilance: Gastrointestinal Related Immune Checkpoint Inhibitor Adverse Events

Postprandial chylomicron output and transport through intestinal lymphatics are not impaired in active Crohn’s disease

Posted on July 14, 2020 by Gastroenterology Journal
Posted in News | Comments Off on Postprandial chylomicron output and transport through intestinal lymphatics are not impaired in active Crohn’s disease

The Influence of Gut and Tumor Microbiome on Pancreatic Cancer Outcomes

Posted on July 14, 2020 by Gastroenterology Journal

Pancreatic cancer is a highly fatal malignancy with overall 5-year survival of under 10%, within the context of increasing incidence rates worldwide (Clin Gastroenterol Hepatol 2020 Mar 5. pii: S1542-3565(20)30276-7 [Epub ahead of print]). Even among t… Continue reading →

Posted in News | Comments Off on The Influence of Gut and Tumor Microbiome on Pancreatic Cancer Outcomes

Clinical Challenges and Images in GI: An extraordinary cause of dyspnoea and weight loss.

Posted on July 13, 2020 by Gastroenterology Journal
Posted in News | Comments Off on Clinical Challenges and Images in GI: An extraordinary cause of dyspnoea and weight loss.

NEW: VUMC team fills COVID information gaps for web users

Posted on July 13, 2020 by Gastroenterology Journal

For the world’s web users, Vanderbilt University Medical Center is working with Google to address COVID-19 information gaps. Continue reading →

Posted in News | Comments Off on NEW: VUMC team fills COVID information gaps for web users